Are Statins Worth It? (Part 1)

In this episode of Nutrition Facts with Dr. Michael Greger, the central question of whether statins are worth it is explored through a deep dive into the science of LDL cholesterol and cardiovascular risk. Dr. Greger explains that LDL cholesterol is the primary driver of atherosclerotic cardiovascular disease, and that lower is better—there appears to be no safe threshold below which further reduction doesn't offer additional protection. Despite this, statins are not prescribed universally due to concerns about side effects and the lifelong commitment to medication. The episode outlines current clinical guidelines: statins are recommended for those with existing heart disease, very high LDL (≥190), diabetes, or a 10-year cardiovascular risk of 7.5% or higher. For intermediate-risk individuals, a coronary calcium scan can help inform the decision. Dr. Greger emphasizes that the final choice must be personal, rooted in informed consent, as patients often overestimate statin benefits and may decline treatment if fully informed. He highlights the gap between relative and absolute risk reduction—while statins reduce relative risk by about one-third, the absolute benefit is often only 1% over three years, which many find underwhelming. Despite this, the public health impact is significant, preventing tens of thousands of deaths annually. The episode also addresses the controversial claim that statins increase diabetes risk, clarifying that this is primarily seen in secondary prevention trials, not primary prevention, and that the cardiovascular benefits typically outweigh this risk. The discussion concludes with a strong advocacy for lifestyle interventions as safe, effective, and essential tools to lower LDL, regardless of statin use.